✦ LIBER ✦

The steepness of the dose response curve both for tumor cure and normal tissue injury

✍ Scribed by J. G. Stewart; A. W. Jackson

Book ID: 115039947
Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 279 KB
Volume: 85
Category: Article
ISSN: 0023-852X
DOI: 10.1288/00005537-197507000-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The high steepness of dose-response curv

The high steepness of dose-response curves for late-responding normal tissues

✍ Thames, H.D.; Hendry, J.H.; Moore, J.V.; Ang, K.K.; Travis, E.L. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 483 KB

The consequences of dose response curves

The consequences of dose response curves for tumor control and normal tissue injury on the precision necessary in patient management

✍ D. F. Herring 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Dose-incidence curves for tumour control

Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells

✍ Moore, J.V.; Hendry, J.H.; Hunter, R.D. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 1009 KB

Dose escalation, treatment protraction,

Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck

✍ Yaes, Robert J. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Dose escalation, treatment protraction,

Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck

✍ Bentzen, Søren M. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Validity of bioeffect dose response mode

Validity of bioeffect dose response models for normal tissue early and late complications of the skin

✍ Sanjay S. Supe; B.S. Rana; Shubha Jyothi; T. Naveen; Jacob Samuel; J.G.R. Solomo 📂 Article 📅 2007 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 116 KB

## Background The bioeffect of a physical dose depends on the nature of the tissue, fractionation scheme, dose rate and treatment time. Certainly, experienced radiotherapists are convinced of the existence of patient-to-patient variability in normal tissue response to radiotherapy for malignant tu